PHARMACY

Frost & Sullivan report: Global diabetes market will increase

BY Alaric DeArment

LONDON Increased knowledge of the pathology of diabetes will lead to improved drugs to treat the disease, according to a new report by market research firm Frost & Sullivan.

The report, Global Diabetes Market, found that the market earned revenues of $27 billion last year and is estimated to reach $44.7 billion by 2015.

“Improved therapies and innovative drug delivery techniques are anticipated to revolutionize the global diabetes market by 2015,” Frost & Sullivan program leader Sylvia Miriyam Findlay said in a statement. “As health care moves towards preventive medicine, the search for a cure for diabetes looks promising.”

The report noted that the market landscape is changing because of the introduction of new drug classes, such as GLP-1 analogs, such as Byetta (exenatide), made by Eli Lilly & Co., Amylin Pharmaceuticals and Alkermes.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Researchers discover ways to prevent infection of cells

BY Alaric DeArment

MADISON, Wis. Researchers at the University of Wisconsin-Madison have found a way to block biological communications between cells that lead to viral infections and tumors.

In a study supported by grants from the National Institutes of Health and published online in the Proceedings of the National Academy of Sciences, a team of researchers from UW-Madison and other universities created a set of synthetic molecules that interacted with the HIV protein gp41 to prevent the infection of cells. Several viruses, including HIV, Ebola and influenza, use interactions between viral and cellular proteins to infect cells.

“There’s a lot of information transfer that occurs when proteins come together, and one would often like to block that information flow,” UW-Madison chemistry professor Samuel Gellman said in a statement.

While it remains unclear whether this method can be used to create anti-HIV drugs, Gellman said it did could potentially lead to new ways of thinking about designing antiviral drug molecules.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Behavioral Health Central to relaunch Web portal

BY Antoinette Alexander

CONSHOHOCKEN, Pa. In an effort to bring together clinicians, patients, payers, executives and administrators on one central Web portal, Behavioral Health Central is relaunching the www.BehavioralHealthCentral.com site.

The new Web portal provides industry and clinical news, resources and tools, and social networking capabilities designed to bring together all of the major stakeholders in behavioral healthcare. 

“This new genesis of our site brings everyone to the table so they all have access to similar resources and information,” stated Jim Miller, president of BHC. “It’s a recognition that, in the end, we’re all striving for the same thing — better treatment pathways, leading to improved outcomes for patients.”

Another key feature of the new site is the addition of nationwide directories that allow professionals and consumers to quickly locate treatment facilities, therapists, vendors, drug information, association lists and more.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?